Key Insights Significant control over Greenfire Resources by private equity firms implies that the general public ...

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an ...

EGFR(S468R), ACVR2A/B, FZD7, and ALK7. Notably, the team successfully designed antibodies targeting ALK7, a protein without an experimentally resolved structure, as well as antibodies targeting a ...

With chronic kidney disease projected to be the fifth leading cause of death by 2040, Nephrologist Dr. Adrian Sawyer is ...

This study, they added, addresses this gap, demonstrating that even a short history of cognitive impairment can increase death risk by nearly 50% in younger adult patients (mean age 60.5 years) with ...

In collaboration with Professor Young-Tae Chang's team, they identified its structure using mass spectrometry ... that epidermal growth factor receptor (EGFR)—a key regulator of cell growth ...

Assessment of transfer entropy is useful for network analysis of cell signaling network providing information on the network topology and action points of genetic mutations and drug effect, thus will ...

These discoveries suggest that targeting Hh and EGFR signaling to stimulate stem ... because the meibomian glands of mice have a similar structure to those in humans and, like the human glands ...

AstraZeneca has built its leading presence in the pharma and biotech industry on patent-protected drugs and a developing pipeline that support a wide moat. The strong replenishment of new drugs sets ...

These discoveries suggest that targeting Hh and EGFR signaling to stimulate stem ... because the meibomian glands of mice have a similar structure to those in humans and, like the human glands ...